Europe Autoimmune Disease Diagnostics Market Size
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Market Size (2024) | USD 1.38 Billion |
| Market Size (2029) | USD 1.82 Billion |
| CAGR (2024 - 2029) | 5.69 % |
| Market Concentration | Medium |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Europe Autoimmune Disease Diagnostics Market Analysis
The Europe Autoimmune Disease Diagnostics Market size is estimated at USD 1.38 billion in 2024, and is expected to reach USD 1.82 billion by 2029, growing at a CAGR of 5.69% during the forecast period (2024-2029).
The major factors driving the market are the increasing prevalence, along with the rising public awareness, technological advancements, and improved laboratory automation.
European countries are being confronted with an increase in the occurrence of the most autoimmune immune disorders. The prevalence rate of multiple sclerosis in Europe is estimated at 83 out of 100,000. Moreover, multiple sclerosis is more common among women than men. In addition, two million people are affected by rheumatoid arthritis and nearly 2-3% of the population is estimated to be affected by psoriasis, which is one of the most common forms of autoimmune diseases. Owing to the aforementioned conditions, early diagnosis and onset of treatment can make a significant difference in preventing permanent damage and disability. Results of autoimmune disease diagnostic tests can confirm a disorder, estimate disease severity, aid in assessing prognosis. They are also useful to follow disease activity.
The increasing awareness of auto-immune diseases, through programs of research, education, support, and advocacy is a key factor augmenting the usage rates. The European Commission is taking several steps to increase awareness among the public regarding the risk factors in developing autoimmune diseases. Thus, as symptoms occur, they can seek diagnosis and begin a treatment regimen.
Europe Autoimmune Disease Diagnostics Market Trends
This section covers the major market trends shaping the Europe Autoimmune Disease Diagnostics Market according to our research experts:
Rheumatoid Arthritis is Expected to Dominate the Systemic Autoimmune Disease Segment in the Coming Future
Rheumatoid arthritis is a chronic, progressive, and inflammatory autoimmune disease associated with HLA-DR4 and HLA-DR1 serotypes, characterized by persistent inflammation of the synovium that leads to the destruction of joints. The availability of treatment options, such as biologics, increasing awareness about rheumatoid arthritis, and the presence of reimbursement schemes across many countries are driving the growth of the segment. Rheumatoid arthritis (RA) is more prevalent in females. For instance, the United Kingdom has a prevalence rate of 1.2% in females and 0.4% in males.
Increasing incidence of autoimmune diseases, off-label prescription of NSAIDs, and other pain management drugs are expected to increase the demand for RA diagnosis. In addition, extensive focus on the high specificity and sensitivity of RA kits from kit manufacturers, and favorable regulatory guidelines for rapid RA diagnostic kits are expected to fuel the market growth.
Europe Autoimmune Disease Diagnostics Industry Overview
The European autoimmune disease diagnostics market is moderately competitive in nature. Some of the well-known players in the market are Abbott Laboratories, Biomérieux, Bio-rad Laboratories, F. Hoffmann-la Roche, and Thermo Fisher Scientific Inc. However, there are some new companies that are focusing on market penetration, owing to the growing market for autoimmune disease diagnostics in Europe.
Europe Autoimmune Disease Diagnostics Market Leaders
Abbott Laboratories
bioMérieux Inc.
Bio-Rad Laboratories Inc.
Thermo Fisher Scientific Inc.
Siemens Healthineers Inc.
*Disclaimer: Major Players sorted in no particular order
Europe Autoimmune Disease Diagnostics Market Report - Table of Contents
-
1. INTRODUCTION
-
1.1 Study Deliverables
-
1.2 Study Assumptions
-
1.3 Scope of the Study
-
-
2. RESEARCH METHODOLOGY
-
3. EXECUTIVE SUMMARY
-
4. MARKET DYNAMICS
-
4.1 Market Overview
-
4.2 Market Drivers
-
4.2.1 Increasing Prevalence and Rising Public Awareness
-
4.2.2 Technological Advancements and Improved Laboratory Automation
-
-
4.3 Market Restraints
-
4.3.1 Slow Turnaround Time of Results and Need of Multiple Diagnostic Test
-
4.3.2 High Cost
-
-
4.4 Porter's Five Forces Analysis
-
4.4.1 Threat of New Entrants
-
4.4.2 Bargaining Power of Buyers/Consumers
-
4.4.3 Bargaining Power of Suppliers
-
4.4.4 Threat of Substitute Products
-
4.4.5 Intensity of Competitive Rivalry
-
-
-
5. MARKET SEGMENTATION
-
5.1 By Disease Type
-
5.1.1 Systemic Autoimmune Disease
-
5.1.1.1 Rheumatoid Arthritis
-
5.1.1.2 Psoriasis
-
5.1.1.3 Systemic Lupus Erythematosus (SLE)
-
5.1.1.4 Multiple Sclerosis
-
5.1.1.5 Other Systemic Autoimmune Diseases
-
-
5.1.2 Localized Autoimmune Disease
-
5.1.2.1 Inflammatory Bowel Disease
-
5.1.2.2 Type-1 Diabetes
-
5.1.2.3 Thyroid
-
5.1.2.4 Other Localized Autoimmune Diseases
-
-
-
5.2 By Diagnostic Technique
-
5.2.1 Immunofluorescence Assays (IFA)
-
5.2.2 Enzyme-linked Immunosorbant Assay (ELISA)
-
5.2.3 Western Blotting
-
5.2.4 Multiplex Immunoassay
-
5.2.5 Agglutination
-
5.2.6 Other Diagnostic Techniques
-
-
5.3 Geography
-
5.3.1 Europe
-
5.3.1.1 Germany
-
5.3.1.2 United Kingdom
-
5.3.1.3 France
-
5.3.1.4 Italy
-
5.3.1.5 Spain
-
5.3.1.6 Rest of Europe
-
-
-
-
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
-
6.1.1 Abbott Laboratories
-
6.1.2 Biomerieux Inc.
-
6.1.3 Bio-rad Laboratories
-
6.1.4 Euroimmun AG
-
6.1.5 F. Hoffmann-la Roche
-
6.1.6 Inova Diagnostics Inc.
-
6.1.7 Myriad Genetics
-
6.1.8 Siemens Healthineers Inc.
-
6.1.9 Thermo Fisher Scientific Inc.
-
6.1.10 Trinity Biotech PLC
-
- *List Not Exhaustive
-
-
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
Europe Autoimmune Disease Diagnostics Industry Segmentation
An autoimmune disease is a condition that occurs when the immune system mistakenly attacks and destroys healthy body tissue. There are more than 80 different types of autoimmune diseases.
| By Disease Type | |||||||
| |||||||
|
| By Diagnostic Technique | |
| Immunofluorescence Assays (IFA) | |
| Enzyme-linked Immunosorbant Assay (ELISA) | |
| Western Blotting | |
| Multiplex Immunoassay | |
| Agglutination | |
| Other Diagnostic Techniques |
| Geography | ||||||||
|
Europe Autoimmune Disease Diagnostics Market Research FAQs
How big is the Europe Autoimmune Disease Diagnostics Market?
The Europe Autoimmune Disease Diagnostics Market size is expected to reach USD 1.38 billion in 2024 and grow at a CAGR of 5.69% to reach USD 1.82 billion by 2029.
What is the current Europe Autoimmune Disease Diagnostics Market size?
In 2024, the Europe Autoimmune Disease Diagnostics Market size is expected to reach USD 1.38 billion.
Who are the key players in Europe Autoimmune Disease Diagnostics Market?
Abbott Laboratories, bioMérieux Inc., Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc. and Siemens Healthineers Inc. are the major companies operating in the Europe Autoimmune Disease Diagnostics Market.
What years does this Europe Autoimmune Disease Diagnostics Market cover, and what was the market size in 2023?
In 2023, the Europe Autoimmune Disease Diagnostics Market size was estimated at USD 1.31 billion. The report covers the Europe Autoimmune Disease Diagnostics Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Europe Autoimmune Disease Diagnostics Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Europe Autoimmune Disease Diagnostics Industry Report
Statistics for the 2024 Europe Autoimmune Disease Diagnostics market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Europe Autoimmune Disease Diagnostics analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
